Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT1B receptors

Kelly A. Berg, Kenda L.J. Evans, Jodie D. Cropper, William P. Clarke

Resultado de la investigación: Articlerevisión exhaustiva

8 Citas (Scopus)


Coactivation of purinergic (P2Y) receptors reduces agonist efficacy at serotonin1B (5-HT1B), but not 5-HT1A receptors. Herein, we report that pretreatment for 5 min with the P2Y receptor agonist ATP reduced agonist responsiveness at the 5-HT1A, but not at the 5-HT1B, receptor. The effect of ATP pretreatment on the 5-HT1A receptor response rapidly reversed within a 10 min time frame between P2Y receptor and 5-HT1A receptor activation. ATP pretreatment effects on 5-HT1A agonist responsiveness were blocked by the protein kinase inhibitors staurosporine and bisindolylmaleimide, suggesting that the ATP-mediated temporal regulation involves activation of protein kinase C (PKC). Moreover, the temporal effect of ATP was blocked by incubation with 1% ethanol, suggesting that consequences of phospholipase D (PLD) activation play a role. ATP pretreatment blocked the inhibitory effect produced by 5-HT2C receptor activation on the 5-HT1A but not the 5-HT1B, receptor response, suggesting that the 5-HT1A receptor itself was the target for PLD/PKC action. Finally, ethanol did not block the reduction in responsiveness of the 5-HT1A receptor system produced by activation of PKC with phorbol ester treatment, suggesting that PKC activation lies downstream of PLD. Taken together, these data suggest that activation of P2Y receptors can reduce responsiveness of the 5-HT1A receptor system via a PLD/PKC-dependent mechanism that is highly dependent upon the temporal pattern of receptor activation. Moreover, this work underscores the importance of time as a variable in receptor signaling cross talk and serves to further illustrate differences between the 5-HT1A and 5-HT1B receptor systems.

Idioma originalEnglish (US)
Páginas (desde-hasta)200-205
Número de páginas6
PublicaciónJournal of Pharmacology and Experimental Therapeutics
EstadoPublished - ene. 1 2003

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology


Profundice en los temas de investigación de 'Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT1B receptors'. En conjunto forman una huella única.

Citar esto